Nitric oxide dysregulation in patients with heart failure: The association of depressive symptoms with l -arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane

Psychosomatic Medicine

Volumn 77, Issue 3, 2015, Pages 292-302

  Mommersteeg, Paula M C ^a   Schoemaker, Regien G ^b,c   Eisel, Ulrich L M ^b,d   Garrelds, Ingrid M ^e   Schalkwijk, Casper G ^f   Kop, Willem J ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Departments of Cardiology   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 N,N' DIMETHYLARGININE; 8 ISOPROSTANE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; ISOPROSTANE DERIVATIVE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; N,N'-DIMETHYLARGININE; N,N-DIMETHYLARGININE;

AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BECK DEPRESSION INVENTORY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; DYSLIPIDEMIA; EMOTIONAL DISORDER; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MILD RENAL IMPAIRMENT; NEW YORK HEART ASSOCIATION CLASS; OXIDATIVE STRESS; PRIORITY JOURNAL; SCORING SYSTEM; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

AGED; ARGININE; DEPRESSION; FEMALE; HEART FAILURE; HUMANS; ISOPROSTANES; LINEAR MODELS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 84927593600     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000162     Document Type: Article

References (43)

1. Freedland KE, Carney RM, Rich MW. Effect of depression on prognosis in heart failure. Heart Fail Clin 2011; 7:11-21.
2. Schiffer AA, Pelle AJ, Smith OR, Widdershoven J W, Hendriks EH, Pedersen SS. Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure. J Clin Psychiatry 2009;70:1667-73.
3. Fan H, YuW, ZhangQ,Cao H, Li J, Wang J, Shao Y, Hu X. Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-Analysis. Prev Med 2014; 63:36-42.
4. Woltz P C, Chapa DW, Friedmann E, Son H, Akintade B, Thomas SA. Effects of interventions on depression in heart failure: a systematic review. Heart Lung 2012;41: 469-83.
5. Thombs BD, Rosema nM, Coyne JC, de Jonge P, Delisle VC, Arthurs E, Levis B, Ziegelstein RC. Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care An updated systematic review. PLoS One 2013;8:e52654.
6. Kop WJ, Synowski SJ, Gottlieb SS. Depression in heart failure: biobehavioral mechanisms. Heart Fail Clin 2011; 7:23-38.
7. Miller AH,Maletic V,Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol Psychiatry 2009 65 732-41.
8. Pall ML. The NO/ONOO-cycle as the central cause of heart failure. Int J Mol Sci 2013;14:22274-330.
9. Selley ML. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitri c oxide concentrations in the plasma of patients with major depression. J Affect Disord 2004;80:249-56.
10. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 2012;60:1455-69.
11. Anderssohn M, Rosenberg M, Schwedhelm E, Zugck C, Lutz M, Luneburg N, Frey N, Boger RH. The L-Arginine-Asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy. J Card Fail 2012;18: 904-11.
12. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 1998;62:2425-30.
13. Hsu CP, Lin SJ, Chung MY, Lu TM. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure. Atherosclerosis 2012;225:504-10.
14. Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D. N eurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation 2013;10:142.
15. McEvoy MA, Schofield P, Smith W, Agho K, Mangoni AA, Soiza RL, Peel R, Hancock S, Kelly B, Inder K, Carru C, Zinellu A, Attia J. Serum methylarginines and incident depression in a coh ort of older adults. J Affect Disord 2013; 151:493-9.
16. Reimann M, Hamer M, Malan NT, Schlaich MP, Lambert GW, Ziemssen T, Boeger RH, Malan L. Effects of acute and chronic stre ss on the L-Arginine nitric oxide pathway in black and white South Africans: the sympathetic activity and ambulatory blood pressure in Africans study. Psychosom Med 2013;75:751-8.
17. Ito A, Tsao PS, Adi moolam S, KimotoM, Ogawa T, Cooke JP. Novelmechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99:3092-5.
18. Basu S. Bioactive eic osanoids: role of prostaglandin F(2alpha) and F(2)-isoprostanes in inflammation and oxidative stress related pathology. Mol Cells 2010;30:383-91.
19. Morrow JD. The isoprostanes-unique products of arachidonate peroxidation: their role asmediators of oxidant stress. Curr Pharm Des 2006;12:895-902.
20. Davies SS, Roberts LJ 2nd. F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med 2011;50:559-66.
21. Cracowski JL, Tremel F, Marpeau C, Baguet JP, Stanke-Labesque F, Mallion JM, Bessard G. Increased formation of F(2)-isoprostanes in patients with severe heart failure. Heart 2000;84:439-40.
22. Polidori MC, Pratico D, Savino K, Rokach J, Stahl W, Mecocci P. Increased F2 isoprostane plasma levels in patients with congestive heart fa ilure are correlated with antioxidant status and disease severity. J Card Fail 2004;10:334-8.
23. Yager S, Forlenza MJ, Miller GE. Depression and oxidative damage to lipids. Psychoneuroendocrinology 2010; 35:1356-62.
24. Lopresti AL, Maker GL, Hood SD, Drummond PD. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:102-11.
25. Palta P, Samuel LJ, Miller ER 3rd, Szanton SL. Depression and oxidative stress: results from a meta-Analysis of observational studies. Psychosom Med 2014;76:12-9.
26. NaudéPJW, Mommersteeg PMC, Zijlstra WP, Gouweleeuw L, Kupper N, Eisel ULM, Kop WJ, Schoemaker RG. Neutrophil gelatinase-Associated lipocalin and depres sion in patients with chronic heart failure. Brain Behav Immun 2014;38:59-65.
27. Kupper N, Widdershoven JW, Pedersen SS. Cognitive/affective and somatic/affective symptom dimensions of depression a re associated with current and future inflammation in heart failure patients. J Affect Disord 2012;36:567-76.
28. Mommersteeg PMC, Kupper N, Schoormans D, Emons W, Pedersen SS. Health-relate d quality of life is related to cytokine levels at 12 months in patients with chronic heart failure. Brain Behav Immun 2010;24:615-22.
29. Beck AT, Steer RA.Manual for the Revised Beck Depression Inventory. San Antonio: Psychological Corporation; 1993.
30. Strik JJ, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001;42:423-8.
31. Carney RM, Freedland KE. Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease Psychosom Med 2012; 74:33-8.
32. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serumcreatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54.
33. Naude PJW, Csaba N, Eiden LE, Ait-Ali D, van der Heide R, Engelborghs S, Luiten PGM, De Deyn PP, den Boer JA, Eisel ULM. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FA SEB J 2012;26:2811-23.
34. Kronmal RA. Spurious correlation and the fallacy of the ratio standard revisited. J R Stat Soc Ser A Stat Soc 1993; 156:379-92.
35. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 2003;23:1455-9.
36. Sherwood A, Blumenthal JA, Hinderliter AL, Koch GG, Adams KF Jr., Dupree CS, Bensimhon DR, Johnson KS, Trivedi R, Bowers M, Christenson RH, O'Connor CM. Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol 2011;57:418-23.
37. Seljeflot I, Nilsson BB ,Westheim AS, Bratseth V, Arnesen H. The L-Arginine-Asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training. J Card Fail 2011;17:135-42.
38. Wolfram R, Oguogho A, Palumbo B, Sinzinger H. Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF(2alpha). Eur J Heart Fail 2005;7:167-72.
39. Wei H, Mundade R, Lange KC, Lu T. Protein arginine methylation of non-histone proteins and its role in diseases. Cell Cycle 2014;13:32-41.
40. Heringa SM, van den Berg E, Reijmer YD, Nijpels G, Stehouwer CD, Schalkwijk CG, Teerlink T, Scheffer PG, van den Hurk K, Kappelle LJ, Dekker JM, Biessels GJ. Markers of low-grade inflammation and endothelial dysfunction are relat ed to reduced information processing speed and executive functioning in an older population-the Hoorn Study. Psychoneuroendocrinology 2014;40: 108-18.
41. van Sloten TT, Schram MT, Adriaanse MC, Dekk er JM, Nijpels G, Teerlink T, Scheffer PG, Pouwer F, Schalkwijk CG, Stehouwer CD, Henry RM. Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study. Psychol Med 2013;1-14.
42. Direk N, Koudstaal PJ, Hofman A, Ikram MA, Hoogendijk WJ, Tiemeier H. Cerebral hemodynamics and incident depression: the Rotterdam Study. Biol Psychiatry 201 2;72:318-23.
43. Bergheanu SC, van der Laarse A, van der Bom JG, van der Hoeven BL, le Cessie S, de Jong MG, Liem SS, Schalij MJ, Jukema JW. Asymmetric dimethylarginine (ADMA) levels display a morning peak in patient s with acute myocardial infarction. Dis Markers 2011;30:245-52.